Business ❯ Pharmaceutical Industry

Vaccine Development

Moderna Market Impact COVID-19 Vaccines Regulatory Affairs Pfizer mRNA Technology Corporate Governance Market Reactions Moderna Inc. Clinical Trials AstraZeneca Valneva Technology Transfer Investment Partnerships Regulatory Challenges Market Competition Funding Impact Market Authorization Intellectual Property Rights Combination Vaccines Regulatory Approval Legal Accountability Drug Manufacturers Takeda Emergency Use Authorization Market Regulation COVID-19 Response Funding Policies Contracts Risk Management Product Liability Funding Covid-19 Vaccines Corporate Influence Research Funding Bavarian Nordic Investment Risks Market Access Regulatory Policy Funding Projects Product Safety Market Trends Patent Disputes Regulatory Agencies Market Demand COVID-19 Vaccine Manufacturers Investment in Health Stock Market Johnson & Johnson Market Performance Biontech/Pfizer BioNTech Research and Development Investment Trends Innovation in Healthcare Funding Allocations Novavax Corporate Communication Public Trust Market Dynamics Operation Warp Speed

Moderna Begins Phase III Trial of mRNA Bird Flu Vaccine in UK and US

The study tests a fast‑to‑update mRNA shot to boost pandemic readiness against an evolving H5N1 threat.

Pfizer and BioNTech Halt U.S. COVID Vaccine Trial for 50–64-Year-Olds Over Slow Enrollment

FDA Reverses Course To Review Moderna’s mRNA Flu Shot Under Split Pathway

FDA Refuses to File Moderna’s mRNA Flu Vaccine Application Over Trial Comparator

Valneva Pulls U.S. Filings for Chikungunya Vaccine as FDA Halts Trials Over Safety Review

Moderna Scraps CMV Vaccine Program After Phase 3 Failure

FDA Grants Full Approval to Moderna’s Pediatric COVID-19 Vaccine for At-Risk Children

Moderna’s mRNA-1010 Flu Vaccine Outperforms Standard Shot and Advances Toward Approval

FDA Grants Limited Approval to Novavax’s COVID-19 Vaccine